ISRCTN25193534已完成不适用
K PREvention of Cancer by Intervention with SElenium: a pilot randomised controlled feasibility study
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 500 人开始时间: 2001年5月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Volunteers aged 60 - 74 years old, either sex
排除标准
- •Added 12/07/2010:
- •1. Southwest Oncology Group (SWOG) grading scale performance status score greater than 1 or equivalent
- •2. Active liver or kidney disease (known abnormal liver or kidney function)
- •3. Prior diagnosis of cancer (excluding non-melanoma skin cancer)
- •4. Diagnosed human immunodeficiency virus (HIV) infection
- •5. Diminished mental capacity (subjects must be able to give informed consent to participate as defined by ethics committees)
- •6. Taking 50 µg/day or more of selenium supplements
研究者
相似试验
已完成
不适用
Selenium in the Prevention of CancerUnspecified Adult Solid Tumor, Protocol SpecificNCT00022165University of Surrey501
已完成
3 期
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the ProstatePrecancerous/Nonmalignant ConditionProstate CancerNCT00030901SWOG Cancer Research Network619
已完成
不适用
Selenium in the Prevention of CancerCancerNCT01819649Odense University Hospital491
已完成
3 期
S0000 Selenium and Vitamin E in Preventing Prostate CancerProstate CancerNCT00006392SWOG Cancer Research Network35,533
招募中
2 期
selenium in the prevention of pre-procedural myocardial injury in patients undergoing angioplastyIschemic heart diseases patients.Ischaemic heart diseasesI20, I21,IRCT20111206008307N30Tabriz University of Medical Sciences100